Product news from the 08/22/06 News Brief

Share this article:
Oscient Pharmaceuticals has completed its acquisition of the US rights to the cardiovascular product Antara 130 mg (fenofibrate) capsules from Reliant Pharmaceuticals. Antara will be commercialized by Oscient's national sales force beginning later this week. Bristol-Myers Squibb and Otsuka Pharmaceutical have launched Abilify Discmelt (aripiprazole) orally disintegrating tablets, a new oral form of the antipsychotic medication Abilify (aripiprazole) that disintegrates rapidly in the mouth. The FDA approved Abilify Discmelt in June.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.